Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Izzo AA et al. Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. 1998 Trends Pharmacol. Sci. pmid:9803830
Choi IH et al. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. 1998 J. Exp. Med. pmid:9802970
Templeton AG et al. Effects of S-salbutamol on human isolated bronchus. 1998 Pulm Pharmacol Ther pmid:9802957
Hofbauer B et al. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. 1998 Gastroenterology pmid:9797380
Pestonjamasp VK and Burstein SH Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system. 1998 Biochim. Biophys. Acta pmid:9795237
Ohno Y et al. Effects of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig. 1998 Ann. Otol. Rhinol. Laryngol. pmid:9794619
Kaneshiro ES et al. Characterizations of Pneumocystis carinii and rat lung lipids: glyceryl ethers and fatty alcohols. 1998 J. Lipid Res. pmid:9788237
O'Neill C Role of autocrine mediators in the regulation of embryo viability: lessons from animal models. 1998 J. Assist. Reprod. Genet. pmid:9785192
Momose T et al. Effects of intracellular cyclic AMP modulators on human eosinophil survival, degranulation and CD11b expression. 1998 Int. Arch. Allergy Immunol. pmid:9784658
Akisü M et al. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. 1998 Biol. Neonate pmid:9784635
Carlson SA and Jones BD Inhibition of Salmonella typhimurium invasion by host cell expression of secreted bacterial invasion proteins. 1998 Infect. Immun. pmid:9784535
SariahmetoÄŸlu M et al. Effects of WEB 2086 on the protective role of preconditioning against arrhythmias in rats. 1998 Pharmacol. Res. pmid:9782066
Akisü M et al. The effect of L-carnitine on platelet activating factor concentration in the immature rat model of hypoxic-ischemic brain injury. 1998 Acta Med. Okayama pmid:9781268
Serebruany VL et al. Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction. 1998 Cardiology pmid:9778550
Shah BH et al. The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. 1998 Biochem. Pharmacol. pmid:9776305
Suzuki T et al. 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists. 1998 Chem. Pharm. Bull. pmid:9775441
Teather LA et al. Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory. 1998 Neurobiol Learn Mem pmid:9774526
Perez S et al. Inhibition by the anti-mitotic drug doxorubicin of platelet-activating-factor-induced late eosinophil accumulation in rats. 1998 Eur. J. Pharmacol. pmid:9774255
Abu-Zidan FM Hope or hype for lexipafant? 1998 Nature pmid:9774090
Le Blanc K et al. Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera. 1998 Thromb. Res. pmid:9772010